XORTX Therapeutics (XRTX) Notes Payables (2021 - 2026)
XORTX Therapeutics' (XRTX) quarterly Notes Payables came in at $1000.0 in Q1 2026, down 99.69% YoY from $326000.0 in Q1 2025, and down 87.5% on a QoQ basis from $8000.0 in Q4 2025.
XORTX Therapeutics (XRTX) Notes Payables (2021 - 2026) Analysis & Trends
XORTX Therapeutics (XRTX) has 6 years of Notes Payables data on file, last reported at $1000.0 in Q1 2026.
- Quarterly Notes Payables fell 99.69% year-over-year to $1000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1000.0 (down 99.69% YoY) and the FY2025 annual result came in at $8000.0, down 98.6% from the prior year.
- Notes Payables slipped to $1000.0 in Q1 2026, from $8000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $3.8 million in Q4 2022 to a low of $1000.0 in Q1 2026.
- A 5-year average of $1.3 million and a median of $950500.0 in 2024 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2024 — Notes Payables climbed 7.72% — and 2026, when it tumbled 99.69%.
- Tracing XRTX's Notes Payables over 5 years: stood at $3.8 million in 2022, then slumped by 86.19% to $531000.0 in 2023, then rose by 7.72% to $572000.0 in 2024, then slumped by 98.6% to $8000.0 in 2025, then tumbled by 87.5% to $1000.0 in 2026.
- The last three Notes Payables figures came in at $1000.0 (Q1 2026), $8000.0 (Q4 2025), and $101000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.47 Bn | 131.61 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.36 Bn | 78.37 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn |
| 4 | Moderna | 58.99 Bn | 53.85 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.74 Bn | 28.43 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.01 Bn | 9.61 Bn | 668.28 Mn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - |
| 10 | XORTX Therapeutics | 2.84 Mn | 2.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | 8,000.00 |
| Sep 30, 2025 | 101,000.00 |
| Jun 30, 2025 | 177,000.00 |
| Mar 31, 2025 | 326,000.00 |
| Dec 31, 2024 | 572,000.00 |
| Sep 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 1.57 Mn |
| Mar 31, 2024 | 3.22 Mn |
| Dec 31, 2023 | 531,000.00 |
| Dec 31, 2022 | 3.85 Mn |
| Sep 30, 2022 | 1.74 Mn |
| Jun 30, 2022 | 2.15 Mn |
| Mar 31, 2022 | 3.30 Mn |
| Dec 31, 2021 | 3.65 Mn |
| Sep 30, 2021 | 9.02 Mn |